Metzger Michael A Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
23
Insider Sells Sum
$16.76M

Insider Activity of Metzger Michael A

According to the SEC Form 4 filings, Metzger Michael A, being in a position of

  1. Chief Executive Officer at Syndax Pharmaceuticals, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 63793 shares for $1.43M,
    over all time since 2020-11-04, has bought 0 shares, and sold 1198276 shares for $20.84M.

Biography of Metzger Michael A

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $000
Sells
 $1,428,4564100

Comparison of Insiders on Amount of Buys and Sells

2026-07-08SaleSyndax Pharmaceuticals, Inc.
SNDX
Chief Executive Officer
32,375
0.0361%
$24.24$784,776-22.31%
2026-06-01SaleSyndax Pharmaceuticals, Inc.
SNDX
Chief Executive Officer
6,847
0.0078%
$18.99$130,025+1.22%
2026-02-09SaleSyndax Pharmaceuticals, Inc.
SNDX
Chief Executive Officer
17,159
0.0196%
$21.03$360,819-5.14%
2026-02-06SaleSyndax Pharmaceuticals, Inc.
SNDX
Chief Executive Officer
7,412
0.0084%
$20.62$152,835-4.26%
2025-09-08SaleSyndax Pharmaceuticals, Inc.
SNDX
Chief Executive Officer
157,307
0.1836%
$16.41$2.58M+24%
2025-07-16SaleSyndax Pharmaceuticals, Inc.
SNDX
Chief Executive Officer
7,534
0.0088%
$9.29$69,953+115.14%
2025-03-04SaleSyndax Pharmaceuticals, Inc.
SNDX
Chief Executive Officer
7,814
0.0093%
$15.05$117,564+3.27%
2025-02-10SaleSyndax Pharmaceuticals, Inc.
SNDX
Chief Executive Officer
13,288
0.0156%
$15.50$206,017-2.51%
2023-02-06SaleSyndax Pharmaceuticals, Inc.
SNDX
5,959
0.0089%
$27.64$164,697-23.11%
2022-10-06SaleSyndax Pharmaceuticals, Inc.
SNDX
Chief Executive Officer
16,231
0.0248%
$25.29$410,508-17.84%
2022-10-04SaleSyndax Pharmaceuticals, Inc.
SNDX
Chief Executive Officer
1,280
0.002%
$25.02$32,026-13.55%
2022-07-25SaleSyndax Pharmaceuticals, Inc.
SNDX
Chief Executive Officer
31,602
0.0518%
$21.06$665,393+8.22%
2022-07-07SaleSyndax Pharmaceuticals, Inc.
SNDX
Chief Executive Officer
100
0.0002%
$21.00$2,100+15.93%
2022-07-06SaleSyndax Pharmaceuticals, Inc.
SNDX
Chief Executive Officer
15,109
0.0258%
$21.07$318,407+12.52%
2021-12-20SaleSyndax Pharmaceuticals, Inc.
SNDX
90,000
0.1659%
$20.29$1.83M-9.13%
2021-12-17SaleSyndax Pharmaceuticals, Inc.
SNDX
3,352
0.0061%
$19.02$63,754-5%
2021-12-16SaleSyndax Pharmaceuticals, Inc.
SNDX
45,430
0.0887%
$19.08$866,800+2.29%
2021-12-13SaleSyndax Pharmaceuticals, Inc.
SNDX
69,128
0.1397%
$19.05$1.32M+5.74%
2021-10-26SaleSyndax Pharmaceuticals, Inc.
SNDX
32,592
0.0629%
$19.20$625,649-5.81%
2021-10-25SaleSyndax Pharmaceuticals, Inc.
SNDX
89,408
0.1734%
$19.13$1.71M-5.07%
Total: 29
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.